New subvariants KP.2 and KP.3, part of the Omicron lineage, represent 49.2% of Canadian COVID-19 cases. Dr. Isaac Bogoch, infectious disease specialist, suggests varied impacts on individuals, highlighting vaccines' continued effectiveness. Early indications show no immediate concern, emphasizing the importance of individual health factors.
We'll keep you updated on all new application updates and features!